Vol 1, Issue 17

In the coming days, the deaths of Sandra Bland and Harris County Deputy Darren Goforth will continue to jolt statewide conversations about how the Texas criminal justice system deals with — or fails to deal with — mental health issues.

Texas abortion providers on Wednesday asked the U.S. Supreme Court to take up their legal challenge to two provisions of the state's strict abortion law.

In this week's Q&A, we interview Andrew Lee, director of the new Texas Center for Proton Therapy in Dallas.

In this week's Bookshelf, our content partner Kirkus Reviews highlights The Patient's Playbook.

A new study out of Stanford University suggests another benefit for hospitals acquiring doctors' practices.

The Dallas-Fort Worth market, traditionally a high cost area for medical procedures, is home to a number of Affordable Care Organizations that achieved significant savings for Medicare and generated incentives for themselves, according to recent federal data.

Federal funding for biomedical research has fallen 22 percent since 2003, dramatically slowing the pace of development for new drugs and treatments.

A new study has sparked interest and concern among physicians, as it appears to show that a precursor of the protein that triggers Alzheimer’s disease can be transmitted from one person to another under certain conditions.

Newly approved drugs to lower cholesterol are priced much too high, according to the Institute for Clinical and Economic Review.

The rate of increase in drug prices has slowed as insurers and others use a variety of tactics to negotiate lower prices for consumers.

Competitive recruiting among medical schools has launched “a boom in academic poaching” to lure — or retain — top scientists.